The Effect of Aortic Valve Replacement on Left Ventricular Mass Assessed by Echocardiography

European Journal of Echocardiography

Volumn 1, Issue 2, 2000, Pages 116-121

  Vaturi, M ^a   Shapira, Y ^a   Rotstein, M ^a   Adler, Y ^a   Porter, A ^a   Birnbaum, Y ^a   Vered, Z ^b   Sagie, A ^a  

^a RABIN MEDICAL CENTER   (Israel)

^b ASSAF HAROFEH MEDICAL CENTER   (Israel)

Author keywords

Aortic regurgitation; Aortic stenosis; Aortic valve replacement; Echocardiography; Left ventricular mass

Indexed keywords

AGED; AORTA VALVE; ARTICLE; DOPPLER ECHOCARDIOGRAPHY; ECHOGRAPHY; FEMALE; HEART LEFT VENTRICLE HYPERTROPHY; HEART VALVE PROSTHESIS; HUMAN; MALE; MIDDLE AGED; RETROSPECTIVE STUDY; VALVULAR HEART DISEASE;

AGED; AORTIC VALVE; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; HEART VALVE DISEASES; HEART VALVE PROSTHESIS; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 0034197142     PISSN: 15252167     EISSN: None     Source Type: Journal    
DOI: 10.1053/euje.2000.0014     Document Type: Article

References (37)

1. Devereux RB, Reichek N. Echocardiographic determination of left ventricular mass in man: anatomic validation of the method. Circulation. 55:1977;613-618.
2. Weyman AE. Principles and Practice of Echocardiography. 1994;Lea & Febiger, Pennsylvania.
3. Casale PN, Devereux RB, Milner M. Value of echocardiographic measurement of left ventricular mass in predicting cardiovascular morbid events in hypertensive men. Ann Intern Med. 105:1986;173-178.
4. Levy D, Garrison RJ, Savage DD, Kannel WB, Casteli WP. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med. 323:1990;1706-1707.
5. Ghali JK, Liao Y, Simmons B, Castaner A, Cao G, Cooper RS. The prognostic role of left ventricular hypertrophy in patients with or without coronary artery disease. Ann Intern Med. 117:1992;831-836.
6. Kannel WB, Schatzkin A. Sudden death: lessons from subsets in population studies. J Am Coll Cardiol. 5:1985;141B-149B.
7. Koren MJ, Devereux RB, Casale PN, Savage DD, Laragh JH. Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med. 114:1991;345-352.
8. Cooper RS, Simmons BE, Castner A, Santhanam V, Ghali J, Mar M. Left ventricular hypertrophy is associated with worse survival independent of ventricular function and number of coronary arteries severely narrowed. Am J Cardiol. 65:1990;441-445.
9. Yeager M, Yock PG, Popp RL. Comparison of Doppler-derived pressure gradient to that determined at cardiac catheterization in adults with aortic valve stenosis: Implication for management. Am J Cardiol. 57:1986;644-648.
10. Grayburn PA, Handshoe R, Smith MD, Harrison MR, Demaria AN. Qualitative assessment of the hemodynamic consequences of aortic regurgitation by means of continuous wave Doppler recordings. J Am Coll Cardiol. 10:1987;135-141.
11. Bouchard A, Yock P, Schiller NB. Value of color Doppler estimation of regurgitation volume in patients with chronic aortic insufficiency. Am Heart J. 117:1989;1099-1105.
12. Reynolds T, Abate J, Tenney A, Warner MG. The JH/LVOH method in the quantification of aortic regurgitation: How the cardiac sonographer may avoid an important potential pitfall. J Am Soc Echocardiogr. 4:1991;105-108.
13. Bikkina M, Larson MG, Levy D. Asymptomatic ventricular arrhythmias and mortality risk in subjects with left ventricular hypertrophy. J Am Coll Cardiol. 22:1993;1111-1116.
14. Levy D. Clinical significance of left ventricular hypertrophy: insights from the Framingham Study. J Cardiovasc Pharmacol. 17:1991;S1-6.
15. He GW, Grunkemeier GL, Gately HL, Furnary AP, Starr A. Up to thirty-year survival after aortic valve replacement in the small aortic root. Ann Thorac Surg. 59:1995;1056-1062.
16. Lund O, Pilegaard HK, Magnussen K, Knudsen MA, Nielsen TT, Albrechtsen OK. Long-term prosthetic-related and sudden cardiac-related complications after aortic valve replacement for aortic stenosis. Ann Thorac Surg. 50:1990;396-406.
17. Lytle BW, Cosgrove DM, Taylor PC. Primary isolated aortic valve replacement: early and late results. J Thorac Cardiovasc Surg. 97:1989;77-89.
18. Rohde LE, Zhi G, Aranki SF, Beckel NE, Lee RT, Reimold SC. Gender-associated with left ventricular geometry in patients with aortic valve disease and effect of distinct overload subsets. Am J Cardiol. 80:1997;475-480.
19. Krumholz HM, Larson M, Levy D. Sex difference in cardiac adaptation to isolated systolic hypertension. Am J Cardiol. 72:1993;310-313.
20. Grossman W, Jones D, McLaurin LP. Wall stress and patterns of hypertrophy in the human left ventricle. J Clin Invest. 56:1975;56-64.
21. Grossman W. Cardiac hypertrophy: useful adaptation or pathologic process? Am J Med. 69:1980;576-584.
22. Cohn LH. The long-term results of aortic valve replacement. Chest. 85:1984;387-396.
23. Pannidis IP, Kotler MN, Ren JF, Mintz GS, Ross J, Kalman P. Development and regression of left ventricular hypertrophy after aortic valve replacement. J Am Coll Cardiol. 3:1984;1309-1320.
24. Monard ES, Hess OM, Tomoyuki M, Monogi H, Corin WJ, Krayenbuehl HP. Time course of regression of left ventricular hypertrophy after aortic valve replacement. Circulation. 77:1988;1345-1355.
25. Kennedy JW, Doces J, Stewart DK. Left ventricular function before and following aortic valve replacement. Circulation. 56:1977;944-950.
26. Krayenbuehl H, Hess OM, Monard S, Schneider J, Mall G, Turina M. Left ventricular myocardial structure in aortic valve disease before, intermediate, and after aortic valve replacement. Circulation. 79:1989;744-755.
27. Christakis GT, Joyner CD, Morgan CD. Left ventricular mass regression early after aortic valve replacement. Ann Thorac Surg. 62:1996;1084-1089.
28. Sen S, Tarazi RC, Bumpus FM. Effect of converting enzyme inhibitor (SQ 14225) on myocardial hypertrophy in spontaneously hypertensive rats. Hypertension. 2:1980;169-176.
29. Cutilletta AF. Regression of myocardial hypertrophy. RNA synthesis and RNA polymerase activity. J Mol Cell Cardiol. 12:1980;827-832.
30. Brilla CG, Matsubara L, Weber KT. Advanced hypertensive heart disease in spontaneously hypertensive rats. Lisinopril-mediated regression of myocardial fibrosis. Hypertension. 28:1996;269-275.
31. Jin XY, Gibson DG, Yacoub MH, Pepper JR. Perioperative assessment of aortic homograft, Toronto stentless valve, and stented valve in aortic position. Ann Thorac Surg. 60:1995;S395-401.
32. Jin XY, Zhang ZM, Gibson DG, Yacoub MH, Pepper JR. Effects of valve substitute on changes in left ventricular function and hypertrophy after aortic valve replacement. Ann Thorac Surg. 62:1996;683-690.
33. Sim EKW, Orszulak TA, Schaff HV, Shub C. Influence of prosthesis size on change in left ventricular mass following aortic valve replacement. Eur J Cardiothorac Surg. 8:1994;293-297.
34. Lund O, Emmertsen K, Nielsen TT. Impact of size mismatch and left ventricular function on performance of the St. Jude disc valve after aortic valve replacement. Ann Thorac Surg. 63:1997;1227-1234.
35. Henry WL, Bonow RO, Borer JS. Evaluation of aortic valve replacement in patients with valvular aortic stenosis. Circulation. 61:1980;814-825.
36. Sutton MSJ, Plappert T, Speigel A. Early postoperative changes in left ventricular chamber size, architecture, and function in aortic stenosis and aortic regurgitation and their relation to intraoperative changes in afterload: a prospective two-dimensional echocardiographic study. Circulation. 76:1987;77-89.
37. Monard ES, Hess OM, Murakami T, Nonogi H, Corin WJ, Krayenbuehl HP. Time course of regression of left ventricular hypertrophy after aortic valve replacement. Circulation. 77:1988;1345-1355.